MX379367B - Kit para marcaje radiactivo con galio 68 (68ga) que comprende un inhibidor de metal. - Google Patents

Kit para marcaje radiactivo con galio 68 (68ga) que comprende un inhibidor de metal.

Info

Publication number
MX379367B
MX379367B MX2017002362A MX2017002362A MX379367B MX 379367 B MX379367 B MX 379367B MX 2017002362 A MX2017002362 A MX 2017002362A MX 2017002362 A MX2017002362 A MX 2017002362A MX 379367 B MX379367 B MX 379367B
Authority
MX
Mexico
Prior art keywords
kit
gallium
radioactive labeling
metal inhibitor
radiolabelling
Prior art date
Application number
MX2017002362A
Other languages
English (en)
Other versions
MX2017002362A (es
Inventor
André Luxen
Geoffroy Kaisin
Ludovic Wouters
Marc Léonard
Samuel Voccia
Original Assignee
Anmi S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anmi S A filed Critical Anmi S A
Publication of MX2017002362A publication Critical patent/MX2017002362A/es
Publication of MX379367B publication Critical patent/MX379367B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0497—Organic compounds conjugates with a carrier being an organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0474—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group
    • A61K51/0482—Organic compounds complexes or complex-forming compounds, i.e. wherein a radioactive metal (e.g. 111In3+) is complexed or chelated by, e.g. a N2S2, N3S, NS3, N4 chelating group chelates from cyclic ligands, e.g. DOTA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/008—Peptides; Proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/05—Isotopically modified compounds, e.g. labelled

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Radiation-Therapy Devices (AREA)
  • Steroid Compounds (AREA)

Abstract

La presente invención se relaciona con un kit para el marcaje radiactivo de un agente enfocado con galio-68. La presente invención también se refiere al uso de tal kit para el marcaje radiactivo de un agente enfocado, un método para el marcaje radiactivo de un agente enfocado con galio-68 usando tal kit, tal kit y un método de preparación.
MX2017002362A 2014-08-29 2015-07-28 Kit para marcaje radiactivo con galio 68 (68ga) que comprende un inhibidor de metal. MX379367B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
BE2014/0653A BE1021191B1 (fr) 2014-08-29 2014-08-29 Kit pour radiomarquage.
PCT/EP2015/067211 WO2016030103A1 (en) 2014-08-29 2015-07-28 Kit for radiolabelling with 68ga comprising a metal inhibitor

Publications (2)

Publication Number Publication Date
MX2017002362A MX2017002362A (es) 2017-09-15
MX379367B true MX379367B (es) 2025-03-11

Family

ID=52396314

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2017002362A MX379367B (es) 2014-08-29 2015-07-28 Kit para marcaje radiactivo con galio 68 (68ga) que comprende un inhibidor de metal.
MX2017002361A MX388098B (es) 2014-08-29 2015-07-28 Mono-, di-, o polisacarido usado como inhibidor de metal en la preparacion del agente enfocado funcionalizado con quelato galio 68 (68ga).

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2017002361A MX388098B (es) 2014-08-29 2015-07-28 Mono-, di-, o polisacarido usado como inhibidor de metal en la preparacion del agente enfocado funcionalizado con quelato galio 68 (68ga).

Country Status (20)

Country Link
US (7) US11040120B2 (es)
EP (4) EP3862025A1 (es)
JP (2) JP6543343B2 (es)
CN (2) CN106659806B (es)
AU (7) AU2015309187B2 (es)
BE (1) BE1021191B1 (es)
BR (3) BR122021017474B1 (es)
CA (3) CA3167294C (es)
DK (1) DK3185911T3 (es)
ES (2) ES2855991T3 (es)
FR (1) FR25C1028I1 (es)
HU (1) HUE053971T2 (es)
IL (2) IL250735B (es)
MX (2) MX379367B (es)
NZ (1) NZ729293A (es)
PL (1) PL3185911T3 (es)
PT (1) PT3185911T (es)
RU (2) RU2724894C2 (es)
WO (2) WO2016030104A1 (es)
ZA (1) ZA201702152B (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE1021191B1 (fr) * 2014-08-29 2015-10-27 Anmi S.A. Kit pour radiomarquage.
US11027030B2 (en) 2014-08-29 2021-06-08 Anmi S.A. Kit for radiolabelling
GB201504064D0 (en) * 2015-03-10 2015-04-22 Accretion Biotechnology Ltd Method and kits for preparing radionuclide complexes
CN106377527B (zh) * 2016-09-05 2019-02-26 郑州大学 开链吡啶羧酸衍生物H2dedpa在抗菌领域的应用
MA49398A (fr) 2017-05-05 2020-04-22 Eric Steven Burak Anticorps monoclonaux anti-igf-1r et utilisations de ceux-ci
US10093741B1 (en) 2017-05-05 2018-10-09 Fusion Pharmaceuticals Inc. IGF-1R monoclonal antibodies and uses thereof
JP7693317B2 (ja) 2017-05-05 2025-06-17 センター・フォー・プローブ・デベロップメント・アンド・コマーシャライゼイション 二官能性キレートの薬物動態増強及びその使用
JP7338128B2 (ja) * 2017-12-08 2023-09-05 イー、シー、エス、ビオトラッカー、エス、エー、アール、エル 癌診断における放射性標識プロガストリン
US20210276971A1 (en) * 2018-06-20 2021-09-09 The Research Foundation For The State University Of New York Triazamacrocycle-derived chelator compositions for coordination of imaging and therapy metal ions and methods of using same
CN110787186B (zh) * 2019-10-22 2020-11-17 华中科技大学 一种Ga3+/PDA靶向协同抗菌纳米材料、其制备和应用
IT202000032603A1 (it) 2020-12-29 2022-06-29 Univ Degli Studi Di Bari Aldo Moro Kit freddi a base di ligandi del psma per l’allestimento di radiofarmaci.
CN117500772A (zh) 2021-05-31 2024-02-02 泰利克斯制药(创新)私人有限公司 改进的前列腺特异性膜抗原靶向放射性药物及其用途
MX2024000041A (es) 2021-06-29 2024-04-26 Life Molecular Imaging Ltd Un kit novedoso para la preparación radiofarmacéutica de un conjugado de direccionamiento funcionalizado con quelato, marcado con radiometal.
WO2025242848A1 (en) * 2024-05-23 2025-11-27 Telix Innovations S.A. Radiolabelling kit and method for radiolabelling with 68ga or 67ga
WO2026013238A2 (en) * 2024-07-12 2026-01-15 Telix Innovations S.A. Radiolabelling kit and method for radiolabelling with zirconium-89

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7902342A (nl) 1979-03-26 1980-09-30 Byk Mallinckrodt Cil Bv Isotopengenerator.
WO2003048207A2 (en) * 2001-11-28 2003-06-12 Immunomedics, Inc. Anti-dota antibody
US7011816B2 (en) * 2001-12-26 2006-03-14 Immunomedics, Inc. Labeling targeting agents with gallium-68 and gallium-67
AU2003213730A1 (en) 2002-03-01 2003-09-16 Bracco International B.V. Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy
US7597876B2 (en) * 2007-01-11 2009-10-06 Immunomedics, Inc. Methods and compositions for improved F-18 labeling of proteins, peptides and other molecules
GB0308408D0 (en) 2003-04-11 2003-05-21 Amersham Plc Microwave activation
SG177216A1 (en) * 2003-07-24 2012-01-30 Bracco Imaging Spa Stable radiopharmaceutical compositions and methods for their preparation
BRPI0606395A2 (pt) * 2005-01-05 2009-06-23 Univ Texas conjugados para ambas imagem e radioquimioterapia: composição, fabricação e aplicações
US8545809B2 (en) * 2007-01-11 2013-10-01 Immunomedics, Inc. Methods and compositions for improved 18F labeling of proteins, peptides and other molecules
MX340566B (es) 2007-03-27 2016-07-14 Radiomedix Inc Composiciones para formacion de imagen objetivo y terapia.
FR2942227B1 (fr) 2009-02-13 2011-04-15 Guerbet Sa Utilisation de tampons pour la complexation de radionucleides
US20120164111A1 (en) * 2009-04-14 2012-06-28 Kurt Osther Novel post-translational fibrinogen variants
WO2010141833A2 (en) 2009-06-05 2010-12-09 The General Hospital Corporation Vital fluorochrome conjugates and methods of use
US8951064B2 (en) 2010-12-14 2015-02-10 Ideal Industries, Inc. Terminal structures for wiring devices
ITFI20110180A1 (it) 2011-08-12 2013-02-13 Advanced Accelerator Applic S A Processo per la preparazione di complessi di 68ga.
US9161998B2 (en) * 2012-05-18 2015-10-20 Zentralklinik Bad Berka Gmbh Method and kit for preparing a radiopharmaceutical
US20150246146A1 (en) 2012-10-25 2015-09-03 Life Technologies Corporation Methods and compositions for enzyme-mediated site-specific radiolabeling of glycoproteins
BE1021191B1 (fr) 2014-08-29 2015-10-27 Anmi S.A. Kit pour radiomarquage.
US11027030B2 (en) 2014-08-29 2021-06-08 Anmi S.A. Kit for radiolabelling
CN104830316B (zh) * 2015-05-11 2017-02-01 厦门大学 一种用于核素标记的靶向探针及其制备方法和应用
ITUA20163207A1 (it) 2016-05-06 2017-11-06 Azienda Ospedaliera Di Reggio Emilia Arcispedale Santa Maria Nuova Preparazione in kit di radiofarmaci marcati con gallio-68

Also Published As

Publication number Publication date
JP6552622B2 (ja) 2019-07-31
AU2015309188A1 (en) 2017-03-09
AU2015309188B2 (en) 2020-05-21
US20220273827A1 (en) 2022-09-01
AU2022202439B2 (en) 2023-12-14
CA2958471E (en) 2016-03-03
EP3862025A1 (en) 2021-08-11
PT3185911T (pt) 2021-03-22
EP3862026A1 (en) 2021-08-11
MX2017002362A (es) 2017-09-15
AU2015309187A1 (en) 2017-03-09
WO2016030103A1 (en) 2016-03-03
US20210268131A1 (en) 2021-09-02
US20260102524A1 (en) 2026-04-16
IL250735A0 (en) 2017-04-30
CN106659806B (zh) 2021-01-26
RU2017109582A (ru) 2018-10-01
JP2017526745A (ja) 2017-09-14
EP3185912B1 (en) 2020-12-30
AU2020220193A1 (en) 2020-09-10
RU2017109582A3 (es) 2018-12-20
ZA201702152B (en) 2021-06-30
FR25C1028I1 (fr) 2025-09-19
US20220296735A1 (en) 2022-09-22
BR112017003578B1 (pt) 2023-12-26
RU2725627C2 (ru) 2020-07-03
MX2017002361A (es) 2017-09-15
CA2958471A1 (en) 2016-03-03
ES2855991T3 (es) 2021-09-27
US11040120B2 (en) 2021-06-22
CN106794265B (zh) 2021-01-26
BR112017003710A2 (pt) 2017-12-05
NZ729291A (en) 2021-03-26
AU2024205118A1 (en) 2024-08-15
CA3167294C (en) 2024-05-28
AU2024205118B2 (en) 2026-04-09
US11045563B2 (en) 2021-06-29
CA2958475C (en) 2022-07-12
MX388098B (es) 2025-03-19
PL3185911T3 (pl) 2021-08-23
NZ729293A (en) 2022-04-29
IL250736B (en) 2021-04-29
AU2022202439A1 (en) 2022-05-05
EP3185911A1 (en) 2017-07-05
US20180230068A1 (en) 2018-08-16
BE1021191B1 (fr) 2015-10-27
HUE053971T2 (hu) 2021-07-28
CN106659806A (zh) 2017-05-10
JP2017530188A (ja) 2017-10-12
RU2017109583A3 (es) 2018-12-26
JP6543343B2 (ja) 2019-07-10
AU2015309187B2 (en) 2020-05-21
EP3185912A1 (en) 2017-07-05
ES2856030T3 (es) 2021-09-27
AU2022202346A1 (en) 2022-04-28
AU2020220194A1 (en) 2020-09-10
US20180230069A1 (en) 2018-08-16
BR122021017474B1 (pt) 2023-10-10
DK3185911T3 (da) 2021-03-15
US20210275697A1 (en) 2021-09-09
CA3167294A1 (en) 2016-03-03
CA2958471C (en) 2022-05-31
BR112017003710B1 (pt) 2021-12-14
IL250735B (en) 2021-04-29
RU2724894C2 (ru) 2020-06-26
WO2016030104A1 (en) 2016-03-03
CN106794265A (zh) 2017-05-31
CA2958475A1 (en) 2016-03-03
BR112017003578A2 (pt) 2017-12-05
IL250736A0 (en) 2017-04-30
EP3185911B1 (en) 2020-12-30
US12329829B2 (en) 2025-06-17
RU2017109583A (ru) 2018-10-01

Similar Documents

Publication Publication Date Title
MX2017002362A (es) Kit para marcaje radiactivo con galio 68 (68ga) que comprende un inhibidor de metal.
ZA202107931B (en) Anti-tau antibodies and methods of use
CY1124215T1 (el) Μκ2 αναστολεις και χρησεις αυτων
CL2016002772A1 (es) Composiciones de insulina de rápida acción
CO2018006714A2 (es) 3-azabiciclo[3.1.0]hexanos sustituidos como inhibidores de cetohexoquinasa
EA201791029A1 (ru) Антитела против интерлейкина-33 и их применение
MX2015008999A (es) Inhibidores mk2 y usos de los mismos.
SG10201804931QA (en) Anti-cll-1 antibodies and immunoconjugates
PH12016501873A1 (en) Anti-influenza b virus hemagglutinin antibodies and methods of use
PH12017500019A1 (en) Novel ultra-high performance concrete
SG10201808259TA (en) Anti-jagged1 antibodies and methods of use
BR112017006531A2 (pt) composições, kits e métodos para induzir citorresistência adquirida utilizando indutores de proteínas de estresse
AR102203A1 (es) Composiciones para el cuidado oral que comprenden zinc, arginina y serina
CL2016001701A1 (es) Material de enlucido de yeso que contiene un complejo metálico de edta
SG10201808278TA (en) Polishing composition and polishing method
MX390924B (es) Detergentes y agentes de limpieza que comprenden una combinación de amilasa y proteasa.
CL2017000074A1 (es) Antagonistas de reproducción de peces
BR112018006446A2 (pt) composições lubrificantes e métodos para uso das mesmas
MX2021005080A (es) Composiciones que comprenden acido 15-hidroxieicosapentaenoico (15-hepe) y metodos para tratar o prevenir la fibrosis usando las mismas.
PH12017502148A1 (en) Pharmaceutical compositions and use thereof
MX2018012900A (es) Uso de beta-agonistas del receptor de la hormona tiroidea.
DK3706710T3 (da) Formuleringer med forlænget frigivelse til intraartikulære anvendelser
MX2018012904A (es) Uso de beta-agonistas del receptor de la hormona tiroidea.
IL270823A (en) Insulating factors, kits for them, and methods for using insulating factors and kits for them
MX2017004909A (es) Composiciones de triptamina y metodos de uso.